Vemircopan (ALXN2050) monotherapy in paroxysmal nocturnal hemoglobinuria: Interim data from a phase 2 open-label proof-of-concept study

被引：0
|
作者：
Browett, Peter [1 ]
Kulasekararaj, Austin [2 ,3 ]
Notaro, Rosario [4 ,5 ]
Ogawa, Masayo [6 ]
Risitano, Antonio [7 ,8 ]
Yu, Ji [6 ]
Lee, Jong Wook [9 ]
机构：
[1] Univ Auckland, Auckland, New Zealand
[2] Kings Coll Hosp NHS Fdn Trust, NIHR Wellcome Kings Clin Res Facil, London, England
[3] Kings Coll London, London, England
[4] Azienda Osped Univ Careggi, Florence, Italy
[5] Inst Studio Prevenz & Rete Oncol, Florence, Italy
[6] Alexion, AstraZeneca Rare Dis, Boston, MA USA
[7] Federico II Univ Naples, Naples, Italy
[8] AORN Moscati, Avellino, Italy
[9] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Seoul, South Korea
来源：
IMMUNOBIOLOGY | 2023年 / 228卷 / 05期
关键词：
D O I：
10.1016/j.imbio.2023.152638
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
188
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [21] Tocilizumab monotherapy after ultra-short glucocorticoid administration in giant cell arteritis: a single-arm open-label, proof-of-concept study
    Christ, Lisa
    Seitz, Luca
    Scholz, Godehard
    Sarbu, Adela-Cristina
    Amsler, Jennifer
    Buetikofer, Lukas
    Tappeiner, Christoph
    Kollert, Florian
    Reichenbach, Stephan
    Villiger, Peter M.
    LANCET RHEUMATOLOGY, 2021, 3 (09): : E619 - E626
  • [22] A phase 1b, open-label, investigator-initiated, proof-of-concept study of pembrolizumab for advanced basal cell carcinomas
    Chang, Anne
    Duy Tran
    Cannon, John
    Li, Shufeng
    Jeng, Mark
    Rieger, Kerri
    Reddy, Sunil
    Sarin, Kavita
    Colevas, Dimitrios
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB8 - AB8
  • [23] A Pilot, Open-Label, Proof-of-Concept Study To Evaluate the Efficacy and Safety of Asthiposhak® Tablets in Participants Suffering From Asthikshaya or Osteopenia
    Kumar, Khushal
    Godatwar, Pawankumar
    Sharma, Sanjeev
    Narvekar, Sangam
    Nalawade, Megha
    Chawda, Mukesh B.
    Verma, Pragya
    Seetharaman, Rajmohan
    Tripathi, Raakhi K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [24] Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial
    Weishaupt, Carsten
    Stroelin, Anke
    Kahle, Birgit
    Kreuter, Alexander
    Schneider, Stefan W.
    Gerss, Joachim
    Eveslage, Maria
    Drabik, Attyla
    Goerge, Tobias
    LANCET HAEMATOLOGY, 2016, 3 (02): : E72 - E79
  • [25] Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study
    McDade, Eric
    Cummings, Jeffrey L.
    Dhadda, Shobha
    Swanson, Chad J.
    Reyderman, Larisa
    Kanekiyo, Michio
    Koyama, Akihiko
    Irizarry, Michael
    Kramer, Lynn D.
    Bateman, Randall J.
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [26] Lecanemab in patients with early Alzheimer’s disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study
    Eric McDade
    Jeffrey L. Cummings
    Shobha Dhadda
    Chad J. Swanson
    Larisa Reyderman
    Michio Kanekiyo
    Akihiko Koyama
    Michael Irizarry
    Lynn D. Kramer
    Randall J. Bateman
    Alzheimer's Research & Therapy, 14
  • [27] Evaluation of apremilast in chronic pruritus of unknown origin: A proof-of-concept, phase 2a, open-label, single-arm clinical trial
    Clark, Marie
    Wang, Fang
    Bodet, Nancy D.
    Kim, Brian S.
    HEALTH SCIENCE REPORTS, 2020, 3 (02)
  • [28] Trial in Progress: An Open-Label, Phase 2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KP104 in Complement Inhibitor-Naive Subjects with Paroxysmal Nocturnal Hemoglobinuria
    Zhang, Fengkui
    Han, Bing
    He, Guangsheng
    Zhou, Hu
    Wang, Chunrong
    Yue, Changhe
    Ma, Jay
    Rabe, Martin
    Fu, Helen
    He, Chaomei
    Tsui, Ping
    Wu, Jingtao
    Beddingfield, Frederick
    Song, Wenru
    Lee, Richard
    BLOOD, 2022, 140 : 11459 - 11460
  • [29] Somatostatin analogues as second-line treatment in adult patients with recurrent medulloblastoma: A case report and a concept for a multicentric, open-label, proof-of-concept, phase I study
    Glas, M.
    Hirschmann, B.
    Steinbrecher, A.
    Hau, P.
    Bogdahn, U.
    NEURO-ONCOLOGY, 2006, 8 (04) : 341 - 341
  • [30] Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized study
    Jaiswal, Mamta
    Martin, Catherine L.
    Brown, Morton B.
    Callaghan, Brian
    Albers, James W.
    Feldman, Eva L.
    Pop-Busui, Rodica
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (08) : 1287 - 1294
12345